Winning the War against Childhood Cancer
Children shouldn’t experience cancer. The disease should be left to those who’ve spent a few more years on this earth.
Back to Hospital after Stem Cell Transplant
Stem cell transplants can – and do – save the lives of very sick kids. New research has discovered that the transplant is often just the start of hospital stays for these young patients.
Completely New Way to Treat Childhood Cancer
Scientists have entered a brave new world when it comes to treating childhood leukemia. New therapies now being tested may completely change the way one type of blood cancer is treated in children.
Pfizer’s BOSULIF Receives Conditional Marketing Authorization From The European Commission
Pfizer Inc. announced today that the European Commission (EC) has granted conditional marketing authorization for BOSULIF ® (bosutinib) in the European Union (EU) for the treatment of adult patients with chronic phase (CP), accelerated phase (AP) and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) previously treated with one or more tyrosine kinase inhibitor(s) (TKIs) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
Personalizing Blood Cancer Treatment
Huge advances have been made in the understanding of multiple myeloma. There are a variety of approaches for treating this blood cancer. The trick is to provide what’s best for the individual patient.
No Need to Fear Lupus Medications
Fear that the treatment for one condition might cause another condition, like cancer, could prevent people from taking needed medications. But should this be a concern for lupus patients?
Battling Fatigue Decades Later
Being tired after any type of cancer therapy is to be expected. Some survivors of childhood cancer, though, can still be battling fatigue many years later.
Closing in On Why Kids Get Cancer
With some forms of cancer, race matters. New research may explain why Hispanic children are more prone to a type of blood cancer.
Closing In on a Cure
Someone diagnosed with any type of leukemia in the early 1960s had about a 14 percent chance of being alive five years later. Today, those chances are vastly greater.
Experimental Treatment May Extend Leukemia Survival
One of the challenges of leukemia is that it likes to return. Once the blood cancer comes back, it’s more difficult to treat and beat. Medical scientists are experimenting with a way to boost the body’s immune system to get in on the fight and win.